Considering cell surface GRP78 is found in cancer but absent or minimally expressed on the surface of non‐malignant tissues [16, 17], this GRP78‐targeting approach may broadly function as a therapeutic gene (e.g., siRNA, mRNA and pDNA) delivery system across various GRP78‐presenting tumors [77]. This evidence concerns the gene HSPA5 and cancer.